Excipient and film coating solutions for OSDF

Ready-formulated systems approach simplifies osmotic pump tablet development and manufacturing.
Harleysville, Pennsylvania, USA, 16 April 2024, Colorcon, a world leader in the development and supply of film coating systems, specialty excipients, and functional packaging for the healthcare industries, launches Corelease OPL™ Controlled Release Osmotic Push Layer for osmotic pump tablets. This launch marks another innovative step in the company's commitment to advancing controlled release technologies for the pharmaceutical industry. 

Colorcon corporate website

Harleysville, Pennsylvania, USA, 23 January 2024. 

Colorcon, a world leader in the development and supply of film coating systems, specialty excipients, and functional packaging for the healthcare industries, announces the launch of a new Opadry® titanium dioxide (TiO2)-free film coating system for pharmaceutical tablets.

Harleysville, Pennsylvania, USA, 5 th December 2023, Colorcon, a world leader in the development and supply of film coating systems, specialty excipients, and functional packaging for the healthcare industries, has consolidated its range of controlled release products under the new Corelease™ Controlled Release Formulated Systems brand. This launch marks a significant milestone in the company's commitment to advancing controlled-release technologies for the pharmaceutical industry. 

Harleysville, Pennsylvania, USA, 2nd March 2023, Colorcon, Inc., a global leader in pharmaceutical film coatings and specialty excipients, today announces that it has completed the acquisition of Airnov Healthcare Packaging, Inc. from Arsenal Capital Partners. 

Atomwise technology removes the barriers of physical screening that have limited the success of traditional methods for small molecule drug discovery.

Customers in the region will have the opportunity to conduct laboratory-scale compression and coating trials, using automated coating equipment.

Acryl-EZE formulations provide significant time savings and targeted drug delivery.

The additional capacity will provide customers with shorter lead times and reduced transportation costs.

Next-generation pharmaceutical supply-chain security for tracking product from plant to patient.

The investment enhances the supply chain robustness of products manufactured for the makers of solid oral dosage products.

Smart tags on pills set to improve supply chain security and patient adherence.